Segment Information (Tables)

12 Months Ended

Dec. 31, 2011

Segment Information [Abstract]

Schedule of Segment Reporting Information

	Agriculture			Electronics & Communications			Industrial Biosciences			Nutrition & Health		Performance Chemicals			Performance Coatings			Performance Materials			Safety & Protection			Pharma- ceuticals		Other			Total
2011
Segment sales	$	9,166		$	3,173		$	705		$	2,460	$	7,794		$	4,281		$	6,815		$	3,934		$	—	$	40		$	38,368
Transfers	(1		)	(19		)	(7		)	—		(257		)	(1		)	(109		)	(13		)	—		—			(407		)
Net sales	9,165			3,154			698			2,460		7,537			4,280			6,706			3,921			—		40			37,961
PTOI	1,527			355			(1		)	44		1,923			271			971			500			289		(263		)	5,616
Depreciation and     amortization	295			99			47			207		252			104			199			172			—		2			1,377
Equity in earnings of     affiliates	58			19			(3		)	—		43			2			74			47			—		(47		)	193
Segment net assets	4,765			1,873			2,544			6,229		3,544			2,107			3,473			3,057			35		70			27,697
Affiliate net assets	330			197			52			1		201			16			445			111			—		34			1,387
Purchases of property,     plant and equipment	420			198			61			115		326			80			197			208			—		5			1,610
2010
Segment sales	$	7,845		$	2,764		$	—		$	1,240	$	6,322		$	3,806		$	6,287		$	3,364		$	—	$	194		$	31,822
Transfers	(1		)	(17		)	—			—		(216		)	(1		)	(69		)	(12		)	—		(1		)	(317		)
Net sales	7,844			2,747			—			1,240		6,106			3,805			6,218			3,352			—		193			31,505
PTOI	1,293			445			—			62		1,081			249			994			454			489		(205		)	4,862
Depreciation and     amortization	265			94			—			109		266			105			205			151			—		4			1,199
Equity in earnings of     affiliates	59			26			—			—		24			2			77			37			—		(45		)	180
Segment net assets	4,927			1,656			—			950		3,317			2,047			3,545			2,967			40		235			19,684
Affiliate net assets	289			195			—			2		184			16			485			103			—		90			1,364
Purchases of property,     plant and equipment	360			260			—			39		225			74			190			215			—		11			1,374
2009
Segment sales	$	7,069		$	1,918		$	—		$	1,218	$	4,964		$	3,429		$	4,768		$	2,811		$	—	$	158		$	26,335
Transfers	—			(20		)	—			—		(145		)	(1		)	(40		)	(11		)	—		(9		)	(226		)
Net sales	7,069			1,898			—			1,218		4,819			3,428			4,728			2,800			—		149			26,109
PTOI	1,160			87			—			64		547			69			287			260			1,037		(171		)	3,340
Depreciation and     amortization	331			88			—			108		267			123			249			147			—		4			1,317
Equity in earnings of     affiliates	47			1			—			—		9			1			37			26			—		(32		)	89
Segment net assets	5,209			1,439			—			1,003		3,257			2,018			3,286			2,257			105		172			18,746
Affiliate net assets	307			190			—			5		152			15			430			84			39		71			1,293
Purchases of property,     plant and equipment	300			237			—			40		192			55			122			228			—		5			1,179

Schedule of Reconciliation of PTOI

PTOI to income before income taxes	2011			2010			2009
Total segment PTOI	$	5,616		$	4,862		$	3,340
Net exchange (losses) gains, including affiliates	(163		)	(13		)	(205		)
Corporate expenses and net interest	(1,171		)	(1,138		)	(951		)
Income before income taxes	$	4,282		$	3,711		$	2,184

Schedule of Reconciliation of Segment Net Assets to Total Assets

Segment net assets to total assets	2011		2010		2009
Total segment net assets	$	27,697	$	19,684	$	18,746
Corporate assets1	10,355		11,312		10,975
Liabilities included in net assets	10,440		9,414		8,464
Total assets	$	48,492	$	40,410	$	38,185

^1.  Pension assets are included in corporate assets.

Reconciliation of Other Significant Reconciling Items from Segments to Consolidated

Other items	Segment Totals		Adjustments			Consolidated Totals
2011
Depreciation and amortization	$	1,377	$	183		$	1,560
Equity in earnings of affiliates	193		(1		)	192
Affiliate net assets	1,387		(270		)	1,117
Purchases of property, plant and equipment	1,610		233			1,843
2010
Depreciation and amortization	$	1,199	$	181		$	1,380
Equity in earnings of affiliates	180		(3		)	177
Affiliate net assets	1,364		(323		)	1,041
Purchases of property, plant and equipment	1,374		134			1,508
2009
Depreciation and amortization	$	1,317	$	186		$	1,503
Equity in earnings of affiliates	89		10			99
Affiliate net assets	1,293		(279		)	1,014
Purchases of property, plant and equipment	1,179		129			1,308

Schedule of Additional Segment Details

2011 included the following pre-tax benefits (charges):

2011
Agriculture1,2	$	(225	)
Industrial Biosciences3,4	(79		)
Nutrition & Health3,4	(126		)
Performance Coatings4	3
Performance Materials4,5	47
Other4	(28		)
	$	(408	)

^1.  Included a $(50) charge recorded in research and development expense in connection with a milestone payment associated with a Pioneer licensing agreement. Since this milestone was reached before regulatory approval was secured by Pioneer, it was charged to research and development expense.

^2.  Included a $(175) charge recorded in cost of goods sold and other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis^®. See Note 15 for additional information.

^3.  Included a $(182) charge for transaction related costs and the fair value step-up of inventories that were acquired as part of the Danisco transaction, which impacted the segments as follows: Industrial Biosciences - $(70) and Nutrition & Health - $(112).

^4.  Included a $(50) restructuring charge primarily related to severance and related benefit costs associated with the Danisco acquisition impacting the segments as follows: Industrial Biosciences - $(9); Nutrition & Health - $(14); Performance Coatings - $3; Performance Materials - $(2); and Other - $(28). See Note 4 for additional information.

^5.  Included a $49 benefit recorded in other income, net associated with the sale of a business.

2010 included the following pre-tax benefits (charges):

2010
Agriculture1	$	(50	)
Electronics & Communications2	8
Performance Chemicals2	10
Performance Coatings2	(6		)
Performance Materials2	16
Safety & Protection2	5
Other2	1
	$	(16	)

^1.  Included a $(50) charge in research and development expense for an upfront payment related to a Pioneer licensing agreement. Since this payment was made before regulatory approval was secured by Pioneer, it was charged to research and development expense.

^2.  Included a $34 net reduction (increase) in estimated restructuring costs related to restructuring programs impacting the segments as follows: Electronics & Communications – $8; Performance Chemicals – $10; Performance Coatings – $(6); Performance Materials – $16; Safety & Protection – $5; and Other – $1.

2009 included the following pre-tax benefits (charges):

2009
Electronics & Communications1,2	$	(37	)
Nutrition & Health1	1
Performance Chemicals1,2	(54		)
Performance Coatings1,2	(15		)
Performance Materials1,2,3	24
Safety & Protection1,2	(45		)
Pharmaceuticals4	(63		)
Other1,2	(2		)
	$	(191	)

^1.  Included a $130 net reduction (increase) in estimated restructuring costs related to the 2008 and 2009 restructuring programs impacting the segments as follows: Electronics & Communications – $6; Nutrition & Health – $1; Performance Chemicals – $12; Performance Coatings – $50; Performance Materials – $52; Safety & Protection – $10; and Other – $(1).

^2.  Included a $(340) restructuring charge impacting the segments as follows: Electronics & Communications – $(43); Performance Chemicals – $(66); Performance Coatings – $(65); Performance Materials – $(110); Safety & Protection – $(55); and Other – $(1).

^3.  Included an $82 benefit from proceeds and adjustments related to hurricanes impacting the Performance Materials segment.

^4.  Included $(63) charge to other income, net and reduction to accounts and notes receivable, net in the Pharmaceuticals segment to reflect increased rebates and other sales deductions related to the Cozaar^®/Hyzaar^® licensing agreement with Merck Sharp & Dohme Corp. This adjustment in 2009 is the result of overstatements to other income, net in prior periods which accumulated over the life of the contract. The company determined the impact of this adjustment was not material to the results of operations in 2009 or for prior periods.